SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

World Health Energy Holdings, Inc. – ‘10-K’ for 12/31/20 – ‘EX-31’

On:  Thursday, 4/15/21, at 5:22pm ET   ·   For:  12/31/20   ·   Accession #:  1493152-21-8940   ·   File #:  0-30256

Previous ‘10-K’:  ‘10-K’ on 4/14/20 for 12/31/19   ·   Next:  ‘10-K’ on 4/14/22 for 12/31/21   ·   Latest:  ‘10-K’ on 4/15/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/21  World Health Energy Holdings, Inc 10-K       12/31/20   59:2.6M                                   M2 Compliance LLC/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    373K 
 2: EX-10.3     Material Contract                                   HTML     25K 
 3: EX-10.4     Material Contract                                   HTML     36K 
 4: EX-21.1     Subsidiaries List                                   HTML     17K 
 5: EX-31       Certification -- §302 - SOA'02                      HTML     21K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     18K 
13: R1          Document and Entity Information                     HTML     52K 
14: R2          Consolidated Balance Sheets                         HTML     88K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
16: R4          Consolidated Statements of Operations and           HTML     50K 
                Comprehensive Loss                                               
17: R5          Consolidated Statements of Changes in               HTML     41K 
                Shareholders' Deficit                                            
18: R6          Consolidated Statements of Cash Flows               HTML     76K 
19: R7          General                                             HTML     33K 
20: R8          Summary of Significant Accounting Policies and      HTML     40K 
                Basis of Presentation                                            
21: R9          Other Current Assets                                HTML     22K 
22: R10         Property and Equipment, Net                         HTML     24K 
23: R11         Other Accounts Liabilities                          HTML     23K 
24: R12         Commitments and Contingencies                       HTML     22K 
25: R13         Shareholders' Equity                                HTML     25K 
26: R14         Research and Development Expenses                   HTML     22K 
27: R15         General and Administrative Expenses                 HTML     23K 
28: R16         Income Tax                                          HTML     33K 
29: R17         Loss Per Share of Common Stock                      HTML     22K 
30: R18         Related Parties                                     HTML     32K 
31: R19         Summary of Significant Accounting Policies and      HTML     77K 
                Basis of Presentation (Policies)                                 
32: R20         Summary of Significant Accounting Policies and      HTML     20K 
                Basis of Presentation (Tables)                                   
33: R21         Other Current Assets (Tables)                       HTML     22K 
34: R22         Property and Equipment, Net (Tables)                HTML     23K 
35: R23         Other Accounts Liabilities (Tables)                 HTML     22K 
36: R24         Research and Development Expenses (Tables)          HTML     22K 
37: R25         General and Administrative Expenses (Tables)        HTML     23K 
38: R26         Income Tax (Tables)                                 HTML     31K 
39: R27         Loss Per Share of Common Stock (Tables)             HTML     22K 
40: R28         Related Parties (Tables)                            HTML     27K 
41: R29         General (Details Narrative)                         HTML     49K 
42: R30         Summary of Significant Accounting Policies and      HTML     23K 
                Basis of Presentation (Details)                                  
43: R31         Other Current Assets - Schedule of Other Current    HTML     25K 
                Assets (Details)                                                 
44: R32         Property and Equipment, Net (Details Narrative)     HTML     19K 
45: R33         Property and Equipment, Net - Schedule of Property  HTML     27K 
                and Equipment, Net (Details)                                     
46: R34         Other Accounts Liabilities - Schedule of Other      HTML     30K 
                Accounts Liabilities (Details)                                   
47: R35         Commitments and Contingencies (Details Narrative)   HTML     25K 
48: R36         Shareholders' Equity (Details Narrative)            HTML     49K 
49: R37         Research and Development Expenses - Schedule of     HTML     31K 
                Research and Development Expenses (Details)                      
50: R38         General and Administrative Expenses - Schedule of   HTML     36K 
                General and Administrative Expenses (Details)                    
51: R39         Income Taxes (Details Narrative)                    HTML     24K 
52: R40         Income Taxes - Schedule of Effective Income Tax     HTML     35K 
                Expense (Details)                                                
53: R41         Income Taxes - Schedule of Deferred Tax Assets      HTML     28K 
                (Details)                                                        
54: R42         Loss Per Share of Common Stock - Schedule of        HTML     19K 
                Weighted Average Number of Shares Basic and                      
                Diluted (Details)                                                
55: R43         Related Parties (Details Narrative)                 HTML     36K 
56: R44         Related Parties - Schedule of Related Party         HTML     29K 
                Transaction (Details)                                            
58: XML         IDEA XML File -- Filing Summary                      XML    101K 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX     61K 
 7: EX-101.INS  XBRL Instance -- when-20201231                       XML    508K 
 9: EX-101.CAL  XBRL Calculations -- when-20201231_cal               XML    141K 
10: EX-101.DEF  XBRL Definitions -- when-20201231_def                XML    278K 
11: EX-101.LAB  XBRL Labels -- when-20201231_lab                     XML    486K 
12: EX-101.PRE  XBRL Presentations -- when-20201231_pre              XML    403K 
 8: EX-101.SCH  XBRL Schema -- when-20201231                         XSD    102K 
59: ZIP         XBRL Zipped Folder -- 0001493152-21-008940-xbrl      Zip     70K 


‘EX-31’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 31

 

Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Giora Rozensweig, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2020, of World Health Energy Holdings, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

April 15, 2021

By: /s/ Giora Rosenzweig  
  Giora Rosenzweig  
  (Principal Executive Officer and Principal Financial and Accounting Officer)  

 

 C: 
 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:4/15/21
For Period end:12/31/20NT 10-K
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  World Health Energy Holdings, Inc 10-K       12/31/23   78:16M                                    M2 Compliance LLC/FA
 4/17/23  World Health Energy Holdings, Inc 10-K       12/31/22   76:6.3M                                   M2 Compliance LLC/FA
 4/14/22  World Health Energy Holdings, Inc 10-K       12/31/21   73:5M                                     M2 Compliance LLC/FA


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/23/20  World Health Energy Holdings, Inc 10-Q        9/30/20   29:1.4M                                   M2 Compliance LLC/FA
 4/30/20  World Health Energy Holdings, Inc 8-K:1,2,3,9 4/27/20    3:442K                                   M2 Compliance LLC/FA
Top
Filing Submission 0001493152-21-008940   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 5:17:55.1am ET